Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke | Zendy

Atte Meretoja | Zendy; Jukka Putaala | Zendy; Turgut Tatlisumak | Zendy; Sari Atula | Zendy; Ville Artto | Zendy; Sami Curtze | Zendy; Olli Häppölä | Zendy; Perttu J. Lindsberg | Zendy; Satu Mustanoja | Zendy; Katja Piironen | Zendy; Janne Pitkäniemi | Zendy; Kirsi Rantanen | Zendy; Tiina Sairanen | Zendy; Oili Salonen | Zendy; Heli Silvennoinen | Zendy; Lauri Soinne | Zendy; Daniel Strbian | Zendy; Marjaana Tiainen | Zendy; Markku Kaste | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke

Author(s) -

Atte Meretoja,

Jukka Putaala,

Turgut Tatlisumak,

Sari Atula,

Ville Artto,

Sami Curtze,

Olli Häppölä,

Perttu J. Lindsberg,

Satu Mustanoja,

Katja Piironen,

Janne Pitkäniemi,

Kirsi Rantanen,

Tiina Sairanen,

Oili Salonen,

Heli Silvennoinen,

Lauri Soinne,

Daniel Strbian,

Marjaana Tiainen,

Markku Kaste

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.576140

Subject(s) - medicine , thrombolysis , stroke (engine) , cardiology , myocardial infarction , mechanical engineering , engineering

Numerous contraindications included in the license of alteplase, most of which are not based on scientific evidence, restrict the portion of patients with acute ischemic stroke eligible for treatment with alteplase. We studied whether off-label thrombolysis was associated with poorer outcome or increased rates of symptomatic intracerebral hemorrhage compared with on-label use.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research